COVAXIN, Bharat Biotech’s coronavirus vaccine and one of the main jabs used in India’s immunization drive, was only 50 per cent effective against symptomatic Covid-19, a real-world study has said.…
Subscribe for our weekly news letter here!
You can unsubscribe us at any time